Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03660098 · ClinicalTrials.gov registry record
Mirror Box Therapy As a Treatment Option for Functional Movement Disorders
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 14
- Enrollment target
NCT03660098 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 14 participants.
The verdict
NCT03660098 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the potential of using mirror box therapy as a therapeutic technique amongst patients with functional movement disorders. It is hypothesized that a brief, single, in-office mirror therapy session will lead to a noticeable decrease in FMD-related involuntary movements.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-06-28 |
| Est. Completion | 2022-05-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03660098
The ClinicalTrials.gov registry entry for NCT03660098 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03660098 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03660098 about?
NCT03660098 is a clinical study titled "Mirror Box Therapy As a Treatment Option for Functional Movement Disorders". The purpose of this study is to investigate the potential of using mirror box therapy as a therapeutic technique amongst patients with functional movement disorders. It is hypothesized that a brief, single, in-office mirror therapy session will lead to a noticeable decrease in FMD-related involuntar...
What is the current status of trial NCT03660098?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2018-06-28. Estimated completion is 2022-05-17.
Who is sponsoring clinical trial NCT03660098?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.